Literature DB >> 24297346

MiniPEG-γPNA.

Arunava Manna1, Srinivas Rapireddy, Raman Bahal, Danith H Ly.   

Abstract

Peptide nucleic acids (PNAs) are attractive, as compared to other classes of oligonucleotides that have been developed to date, in that they are relatively easy to synthesize and modify, hybridize to DNA and RNA with high affinity and sequence selectivity, and are resistant to enzymatic degradation by proteases and nucleases; however, the downside is that they are only moderately soluble in aqueous solution. Herein we describe the protocols for synthesizing the second-generation γPNAs, both the monomers and oligomers, containing MiniPEG side chain with considerable improvements in water solubility, biocompatibility, and hybridization properties.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24297346     DOI: 10.1007/978-1-62703-553-8_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.

Authors:  Karishma Dhuri; Ravinder Reddy Gaddam; Ajit Vikram; Frank J Slack; Raman Bahal
Journal:  Cancer Res       Date:  2021-09-21       Impact factor: 12.701

2.  Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines.

Authors:  Karishma Dhuri; Sai Pallavi Pradeep; Jason Shi; Eleni Anastasiadou; Frank J Slack; Anisha Gupta; Xiao-Bo Zhong; Raman Bahal
Journal:  Pharm Res       Date:  2022-09-07       Impact factor: 4.580

3.  Impact of bPNA Backbone Structural Constraints and Composition on Triplex Hybridization with DNA.

Authors:  Oliver Munyaradzi; Sarah Rundell; Dennis Bong
Journal:  Chembiochem       Date:  2022-02-26       Impact factor: 3.461

4.  Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.

Authors:  Shipra Malik; Jihoon Lim; Frank J Slack; Demetrios T Braddock; Raman Bahal
Journal:  J Control Release       Date:  2020-08-21       Impact factor: 9.776

5.  Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy.

Authors:  Karishma Dhuri; Rutesh N Vyas; Leslie Blumenfeld; Rajkumar Verma; Raman Bahal
Journal:  Cells       Date:  2021-04-25       Impact factor: 7.666

6.  Enhanced Triplex Hybridization of DNA and RNA via Syndiotactic Side Chain Presentation in Minimal bPNAs.

Authors:  Sarah Rundell; Oliver Munyaradzi; Dennis Bong
Journal:  Biochemistry       Date:  2021-12-26       Impact factor: 3.321

7.  γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet.

Authors:  Ravinder Reddy Gaddam; Karishma Dhuri; Young-Rae Kim; Julia S Jacobs; Vikas Kumar; Qiuxia Li; Kaikobad Irani; Raman Bahal; Ajit Vikram
Journal:  J Med Chem       Date:  2022-02-08       Impact factor: 7.446

8.  Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo.

Authors:  Stanley N Oyaghire; Elias Quijano; Alexandra S Piotrowski-Daspit; W Mark Saltzman; Peter M Glazer
Journal:  Methods Mol Biol       Date:  2020

9.  Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy.

Authors:  Anisha Gupta; Elias Quijano; Yanfeng Liu; Raman Bahal; Susan E Scanlon; Eric Song; Wei-Che Hsieh; Demetrios E Braddock; Danith H Ly; W Mark Saltzman; Peter M Glazer
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.